Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice
Charanya Muralidharan(University of Chicago), Raghavendra G. Mirmira(University of Chicago)
Cited by 1
Related Papers
Pancreatic beta cell autophagy is impaired in type 1 diabetes
|Diabetologia|2021|97
Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice
|Journal of Clinical Investigation|2024|18
12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice
|JCI Insight|2024|8
12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1